Vision Mission & Strength
R & D
Niprolac Oral Sol
Starcal D Forte
NIPRO JMI Pharma Ltd. (NJP) is contributing in developing a world-class practicein the pharma industry of Bangladesh by bridling the unment challenges in healthcare sector. It is one of the fastest growing pharmaceutical companies in Bangladesh, started its journey in 2012 with collaboration of NIPRO Corporation; a Japan based giant multinational company, a press release said.
NIPRO JMI Pharma Limited (NJP) has introduced Linagliptin (Lijenta) and Empagliflozin (Empa), which are the breakthroughs in diabetic management and aiding millions of diabetic patients in the country....
NIPRO JMI Pharma Ltd. has celebrated Bangla New Year - 1426 at Corporate office....
Japan Bangladesh joint venture company- NIPRO JMI Pharma held its annual sales conference 2018 at International Convention City, Bashundhara, Dhaka.....
Vurdon SR (Diclofenac Sodium) is a potent non-steroidal anti-inflammatory drug (NSAID)
with pronounced anti-rheumatic, anti-inflammatory, analgesic and antipyretic properties.
It has also some uricosuric effect. Diclofenac exerts its effect by inhibiting prostaglandin
biosynthesis which plays a major role in causing inflammation, pain and fever.
Diclofenac is rapidly and completely absorbed from the gastro-intestinal tract when taken
with or after meal. Peak plasma concentrations are reached within an average of 2 hours
after ingestion of it. At therapeutic concentrations, it is 99.7% bound to plasma proteins.
Diclofenac is metabolized in the liver and undergoes first-pass metabolism.